LTRN — Lantern Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Lantern Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	19.2	70.7	55.2	41.3	24
Prepaid Expenses
Total Other Current Assets
Total Current Assets	20.2	72.7	58.7	43.3	25.2
Net Property, Plant And Equipment	0.022	0.216	0.096	0.28	0.287
Other Long Term Assets
Total Assets	20.4	74	58.8	43.6	25.6
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	0.552	2.33	2.8	2.68	4.33
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.661	2.38	2.8	2.74	4.38
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	19.7	71.6	56	40.9	21.2
Total Liabilities & Shareholders' Equity	20.4	74	58.8	43.6	25.6
Total Common Shares Outstanding